Home›Companies›Biotech & Pharma›PBS Biotech

PBS Biotech, Inc.

Updated Oct 29, 2026·Latest SEC filing Sep 24, 2024·Suggest an edit

About PBS Biotech

PBS Biotech is a private company based in Camarillo, California. It has reported $43,206,775 raised in two offerings on Form D since January 2023. Its chief executive is Brian Lee.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 11, 2024Sep 24, 2024$8,499,999of $16.9M target3$2.8MEquityRule 506(b)Form D ↗
Dec 16, 2022Jan 20, 2023$34,706,776fully sold3$11.5MEquityRule 506(b)Form D ↗
Total, two offerings$43,206,775

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on PBS Biotech's Form D filed Sep 24, 2024.

XL
BL
Brian Lee
Chief Executive Officer and director
DF
MC
Matt Croughan
Executive officer
NB
Nelson Bermudez
Executive officer
TM
Terrell Mathews
Executive officer
DF
LF

Earlier filings also listed Jung Lim (director, last listed Jan 2023) and Bryan Poltilove (director, last listed Jan 2023).

Sources

  1. SECPBS Biotech, Inc. filing history